ArticleNPJ precision oncology2026

Therapeutic vulnerabilities exposed by the 9p21 loss identified through multiparametric drug screening inform rational combination strategies.

Riccardo Bevilacqua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.